Fu-Tong Liu Selected Research

Galectins (Galectin)

5/2021	The Antiviral Role of Galectins toward Influenza A Virus Infection-An Alternative Strategy for Influenza Therapy.
12/2020	The role of galectins in virus infection - A systemic literature review.
1/2020	Galectins in Host Defense Against Microbial Infections.
1/2020	An adipose tissue galectin controls endothelial cell function via preferential recognition of 3-fucosylated glycans.
1/2018	The expression and function of galectins in skin physiology and pathology.
1/2018	Cytosolic galectin-3 and -8 regulate antibacterial autophagy through differential recognition of host glycans on damaged phagosomes.
1/2016	Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors.
2/2014	Galectins as bacterial sensors in the host innate response.
1/2014	Galectins and neuroinflammation.
9/2012	Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fu-Tong Liu Research Topics

Disease

34	Inflammation (Inflammations) 01/2021 - 02/2002
24	Neoplasms (Cancer) 02/2021 - 12/2002
20	Infections 01/2022 - 03/2002
8	Fibrosis (Cirrhosis) 01/2020 - 03/2007
7	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 12/2012
7	Atopic Dermatitis (Atopic Eczema) 01/2018 - 03/2009
6	Carcinogenesis 01/2020 - 06/2010
6	Pathologic Processes 01/2018 - 12/2004
6	Wounds and Injuries (Trauma) 12/2012 - 11/2002
6	Hypersensitivity (Allergy) 01/2010 - 08/2002
5	Skin Diseases (Skin Disease) 01/2022 - 10/2008
5	Asthma (Bronchial Asthma) 01/2019 - 08/2002
5	Neoplasm Metastasis (Metastasis) 02/2016 - 01/2005
5	Autoimmune Diseases (Autoimmune Disease) 10/2013 - 10/2007
5	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 08/2012 - 04/2005
5	Carcinoma (Carcinomatosis) 01/2012 - 02/2002
4	Virus Diseases (Viral Diseases) 05/2021 - 01/2016
4	Dermatitis 01/2020 - 03/2009
4	Melanoma (Melanoma, Malignant) 01/2018 - 05/2006
3	Bacterial Infections (Bacterial Infection) 01/2021 - 02/2014
3	Multiple Sclerosis 01/2021 - 01/2014
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 06/2010
3	Parasitic Diseases (Parasitic Disease) 01/2020 - 02/2007
3	Insulin Resistance 01/2018 - 11/2011
3	Atherosclerosis 01/2018 - 06/2008
3	Obesity 01/2018 - 01/2007
3	Contact Dermatitis (Eczema, Contact) 01/2018 - 03/2009
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 03/2002
3	Basal Cell Carcinoma (Rodent Ulcer) 01/2018 - 02/2005
3	Cholangitis 12/2016 - 02/2011
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 03/2016 - 02/2011
2	Human Influenza (Influenza) 05/2021 - 01/2017
2	Hyperplasia 01/2021 - 01/2018
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 03/2007
2	Mycoses (Diseases, Fungus) 01/2020 - 10/2013
2	Skin Neoplasms (Skin Cancer) 01/2018 - 11/2011
2	Disease Progression 10/2015 - 09/2012
2	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 12/2008
2	Neuroinflammatory Diseases 01/2014 - 09/2012
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2014 - 01/2009
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2014 - 09/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2012 - 03/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2012 - 03/2007
2	Schistosomiasis (Bilharziasis) 01/2012 - 05/2011
2	Schistosomiasis mansoni 01/2012 - 05/2011
2	Toxoplasmosis 06/2010 - 06/2006
2	Chagas Disease (American Trypanosomiasis) 02/2007 - 01/2004
1	Abdominal Aortic Aneurysm 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021

Drug/Important Bio-Agent (IBA)

70	Galectin 3 (LGALS3)IBA 05/2021 - 02/2002
25	Galectins (Galectin)IBA 05/2021 - 03/2002
14	LectinsIBA 01/2021 - 03/2002
14	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2002
10	CytokinesIBA 05/2021 - 02/2002
10	Galectin 1 (LGALS1)IBA 05/2021 - 11/2002
9	Immunoglobulin E (IgE)IBA 12/2012 - 08/2002
8	Polysaccharides (Glycans)IBA 01/2021 - 02/2007
7	Carrier Proteins (Binding Protein)IBA 01/2018 - 11/2002
6	Biological ProductsIBA 01/2020 - 12/2002
6	AllergensIBA 01/2013 - 09/2002
5	Interleukin-17 (Interleukin 17)IBA 01/2021 - 04/2013
4	InflammasomesIBA 05/2021 - 12/2016
4	Interleukin-23 (Interleukin 23)IBA 01/2021 - 04/2013
4	CarbohydratesIBA 09/2012 - 11/2002
3	Monoclonal AntibodiesIBA 01/2017 - 02/2011
3	AntibodiesIBA 08/2014 - 02/2011
3	Messenger RNA (mRNA)IBA 04/2014 - 02/2002
3	ChemokinesIBA 04/2013 - 07/2010
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2012 - 11/2002
3	AntigensIBA 06/2010 - 03/2009
2	Blood Proteins (Serum Proteins)IBA 01/2021 - 10/2006
2	Immunoglobulin G (IgG)IBA 01/2021 - 08/2003
2	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2021 - 01/2018
2	LigandsIBA 01/2020 - 06/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2016
2	XenobioticsIBA 03/2016 - 02/2011
2	Indicators and Reagents (Reagents)IBA 01/2016 - 02/2011
2	HaptensIBA 07/2015 - 03/2009
2	Interleukin-12 (IL 12)IBA 07/2015 - 06/2010
2	Interleukin-4 (Interleukin 4)IBA 08/2014 - 01/2009
2	Interleukin-6 (Interleukin 6)IBA 08/2014 - 06/2010
2	beta CateninIBA 01/2014 - 09/2011
2	Chemokine ReceptorsIBA 08/2012 - 02/2009
2	Ophthalmic Solutions (Eye Drops)IBA 08/2012 - 05/2006
2	LipopolysaccharidesIBA 01/2011 - 08/2008
2	Chemokine CCL11IBA 07/2010 - 02/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 02/2002
2	OvalbuminIBA 03/2009 - 12/2004
1	LipidsIBA 01/2022
1	AndrogensIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 05/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	CaspasesIBA 01/2021
1	Plasma KallikreinIBA 01/2021
1	ADAMTS ProteinsIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021

Therapy/Procedure

4	Therapeutics 05/2021 - 10/2007
2	Oral Administration 01/2018 - 01/2018
1	Injections 01/2021